F. Roblot
Impact in
-
- Antibiotic Use and Resistance
- Parasitology top 1%
- Vector-borne infectious diseases
Papers in
-
- Antifungal resistance and susceptibility 14
- COVID-19 Clinical Research Studies 6
- Parasitology 17
- Vector-borne infectious diseases 14
- Co-authors
- Gwenael Le Moal (33 shared papers)C. Godet (25 shared papers)Bertrand Becq-giraudon (28 shared papers)P. Roblot (25 shared papers)Didier Raoult (6 shared papers)Frédéric Bastides (3 shared papers)Jean‐Marc Besnier (4 shared papers)Patrick Choutet (3 shared papers)
- Journals
- Journal of Infection (7 papers)Scandinavian Journal of Infectious Diseases (7 papers)Journal of Antimicrobial Chemotherapy (6 papers)European Journal of Clinical Microbiology & Infectious Diseases (6 papers)Clinical Microbiology and Infection (5 papers)
- Partner nations
- FranceSwitzerlandBelgium
In The Last Decade
F. Roblot
156 papers receiving 3.7k citations
F. Roblot's Hit Papers
Peers
Comparison fields: 5 of 119
- Applied Microbiology and Biotechnology 228
- Parasitology 408
- Infectious Diseases 1k
- Biotechnology 250
- Microbiology 131
Countries citing papers authored by F. Roblot
This map shows the geographic impact of F. Roblot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Roblot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Roblot more than expected).
Fields of papers citing papers by F. Roblot
This network shows the impact of papers produced by F. Roblot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Roblot. The network helps show where F. Roblot may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Roblot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 168 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 642 | |
| 2 | Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study Hit paper breakdown → | 2017 | 397 |
| 3 | 2002 | 180 | |
| 4 | 2007 | 136 | |
| 5 | 2022 | 132 | |
| 6 | 2006 | 111 | |
| 7 | 2020 | 101 | |
| 8 | 2017 | 93 | |
| 9 | 2020 | 93 | |
| 10 | 2018 | 87 | |
| 11 | 2018 | 83 | |
| 12 | 2003 | 67 | |
| 13 | 2002 | 62 | |
| 14 | 2003 | 58 | |
| 15 | 2016 | 56 | |
| 16 | 2013 | 54 | |
| 17 | 2019 | 49 | |
| 18 | 2008 | 46 | |
| 19 | 2019 | 45 | |
| 20 | 2017 | 43 |
About F. Roblot
F. Roblot is a scholar working on Infectious Diseases, Parasitology, Epidemiology, Applied Microbiology and Biotechnology and Microbiology, having authored 168 papers that have together received 3.9k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (14 papers), Vector-borne infectious diseases (14 papers), Antibiotic Use and Resistance (12 papers), Infective Endocarditis Diagnosis and Management (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers), Neutropenia and Cancer Infections (8 papers), COVID-19 Clinical Research Studies (6 papers) and Infectious Diseases and Tuberculosis (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (228 citations), Parasitology (408 citations), Infectious Diseases (1k citations), Biotechnology (250 citations) and Microbiology (131 citations). F. Roblot has collaborated with scholars based in France, Switzerland and Belgium. Frequent co-authors include Gwenael Le Moal, C. Godet, Bertrand Becq-giraudon, P. Roblot, Didier Raoult, Frédéric Bastides, Jean‐Marc Besnier, Patrick Choutet, Pierre Tattevin and Marie Masson Regnault. Their work appears in journals such as Journal of Infection, Scandinavian Journal of Infectious Diseases, Journal of Antimicrobial Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.